Parliament approved allowing registered cannabis medicines whose safety and effectiveness were supported by research. Ninety members voted in favour and three abstained; the measure awaited the president’s signature and was scheduled to take effect on 1 May 2019. Mykolas Majauskas and Irena Degutienė had promoted the proposal.[1]
Listed for context. No score change is recorded for Lithuania here.
References
Checked. The date and the event were compared with a source that was read.